Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

12 Health Care Stocks Moving In Tuesday's Pre-Market Session

Author: Benzinga Insights | March 12, 2024 09:05am

Gainers

  • Regulus Therapeutics (NASDAQ:RGLS) stock moved upwards by 84.8% to $2.55 during Tuesday's pre-market session. The company's market cap stands at $51.5 million.
  • Assure Hldgs (NASDAQ:IONM) stock increased by 73.02% to $0.59. The market value of their outstanding shares is at $3.9 million.
  • Telomir Pharmaceuticals (NASDAQ:TELO) shares increased by 24.89% to $8.58. The market value of their outstanding shares is at $262.6 million.
  • Bioventus (NASDAQ:BVS) shares increased by 16.0% to $6.16. The market value of their outstanding shares is at $387.8 million. The company's, Q4 earnings came out today.
  • Genelux (NASDAQ:GNLX) stock increased by 14.79% to $7.45. The company's market cap stands at $199.0 million.
  • Kineta (NASDAQ:KA) stock moved upwards by 14.37% to $0.79. The company's market cap stands at $8.2 million.

Losers

  • Renalytix (NASDAQ:RNLX) shares fell 27.2% to $0.83 during Tuesday's pre-market session. The market value of their outstanding shares is at $41.4 million.
  • CytomX Therapeutics (NASDAQ:CTMX) stock declined by 17.63% to $2.07. The company's market cap stands at $138.5 million. As per the press release, Q4 earnings came out yesterday.
  • Psyence Biomedical (NASDAQ:PBM) shares fell 17.52% to $1.46. The market value of their outstanding shares is at $19.5 million.
  • ACADIA Pharmaceuticals (NASDAQ:ACAD) stock fell 16.46% to $20.16. The market value of their outstanding shares is at $3.3 billion.
  • NRX Pharmaceuticals (NASDAQ:NRXP) stock declined by 16.3% to $0.56. The market value of their outstanding shares is at $51.3 million.
  • Finch Therapeutics Gr (NASDAQ:FNCH) shares fell 13.7% to $2.95. The company's market cap stands at $4.7 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Posted In: ACAD BVS CTMX FNCH GNLX IONM KA NRXP PBM RGLS RNLX TELO

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist